Literature DB >> 420467

NIH conference. Primary biliary cirrhosis and the complement system.

.   

Abstract

Primary biliary cirrhosis is a disease characterized by slowly progressive intrahepatic cholestasis, destructive lesions of the septal and larger interlobular bile ducts, and granulomas. It is associated with defects of both humoral and cellular immune function. As part of the detailed evaluation of these defects, the status of the complement system has been evaluated. Striking abnormalities of serum complement levels are found but are difficult to interpret. However, the demonstration of marked hypercatabolism of C3, but not albumin, suggests that the complement system may be in a chronically activated state. Furthermore, an unequivocal defect in the clearance of sensitized erythrocytes by receptors for C3b on Kupffer cells has been found. One possible explanation for this finding would be that a large proportion of these receptors are occupied either by immune complexes containing C3b or excess free C3b that is generated by complement activation. Major defects of C3 catabolism and C3b-receptor-mediated clearance are not found in patients with HBsAg-negative chronic active hepatitis. These findings suggest a role for the complement system in the pathophysiology of primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 420467     DOI: 10.7326/0003-4819-90-1-72

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  9 in total

1.  Impairments in complement receptor- and Fc receptor-mediated functions in vivo in patients with psoriasis.

Authors:  K N Ekdahl; G Michaëlsson; B Gerdén; L Lööf; B Nilsson
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

2.  Primary biliary cirrhosis: an underestimated disorder?

Authors:  D Kelleher; J Jackson; D G Weir; C Feighery
Journal:  Ir J Med Sci       Date:  1986-06       Impact factor: 1.568

Review 3.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

Review 4.  Serology of primary biliary cirrhosis.

Authors:  P A Berg; H Baum
Journal:  Springer Semin Immunopathol       Date:  1980-12

5.  Anticomplement receptor activity in the serum of patients with primary biliary cirrhosis.

Authors:  G Y Minuk; J Vergalla; R G Hanson; J H Hoofnagle; M M Frank; E A Jones
Journal:  Gut       Date:  1986-03       Impact factor: 23.059

6.  Deficiency of the autologous mixed lymphocyte reaction in patients with primary biliary cirrhosis.

Authors:  S P James; C O Elson; J G Waggoner; E A Jones; W Strober
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

7.  Suppression of immunoglobulin synthesis by activated B cells in chronic active liver diseases and primary biliary cirrhosis.

Authors:  S Kakumu; K Fukui; K Yoshioka; H Murakami
Journal:  Gastroenterol Jpn       Date:  1986-02

8.  Circulating activated B cells in primary biliary cirrhosis.

Authors:  S P James; E A Jones; J H Hoofnagle; W Strober
Journal:  J Clin Immunol       Date:  1985-07       Impact factor: 8.317

9.  Depressing hepatic macrophage complement receptor function causes increased susceptibility to endotoxemia and infection.

Authors:  D J Loegering; F A Blumenstock
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.